ANDA 77767, held by Watson Labs. Galantamine Hydrobromide.
As of Nov 15, 2026, ANDA 77767 (Galantamine Hydrobromide), held by Watson Labs, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 30, 2007 | Original application | Tentative approval | None posted |
| Galantamine HydrobromideEQ 4MG BASE · tablet; oral | Galantamine Hydrobromide | None (tentative approval) |
| Galantamine HydrobromideEQ 8MG BASE · tablet; oral | Galantamine Hydrobromide | None (tentative approval) |
| Galantamine HydrobromideEQ 12MG BASE · tablet; oral | Galantamine Hydrobromide | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters